Recruiting

Endovascular Techniques

Sponsor:

St. Louis University

Code:

NCT03999983

Conditions

Vertebral Artery Stenosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Observational Prospective Registry

Study Details

Brief summary:

A retrospective and prospective registry of patients admitted for stroke and evidence of Vertebral Artery Origin Stenosis (VAOS).

Conditions

Vertebral Artery Stenosis

Study ID

NCT03999983

Start date

Nov 19, 2019

Status verified date

Feb, 2025

Completion date

Dec, 2026

Anticipated

Primary completion date

Mar, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Patients between 18 and 90 years of age
2. Patient has experienced a posterior circulation ischemic event
3. Patient has angiographically confirmed bilateral vertebral artery origin disease (Hypoplasia, occlusion, or stenosis).
4. Patient has >50% stenosis on the side being targeted for therapy

Exclusion Criteria:

1. Pregnant women
2. Contrast Indication to the use of anti-platelet drugs
3. There is tandem vertebral or basilar artery stenosis
4. The serum creatinin is >2.5
5. Baseline modified Rankin score is >3
6. < 5 years life expectancy

Study Design

Enrollment

150 participants

Anticipated

Interventions and Outcome Measures

Interventions

Observational Prospective Registry

This is a prospective registry looking at patients admitted for stroke with evidence of Vertebral Artery Origin Stenosis. Patients clinical outcomes will be collected at 30 days and 1-year post-treatment and angiographic outcomes at 1-year post-treatment

Primary outcome measure

  • Incidence of recurrent stroke or death [ Time Frame: 1 Year post-treatment ]

Central Contacts and Locations

Central contacts

Locations

Baptist Medical Center Jacksonville

Recruiting

Jacksonville, Florida, United States, 32207

Contacts

Nancy Ebreo, CCRC,RRT,CRA

Nancy.ebreo@bmcjax.com

Principal Investigator:

Nima Aghaebrahim, MD

University of Southern Florida

Recruiting

Tampa, Florida, United States, 33606

Contacts

Waldo Guerrero, MD

wrguerre@usf.edu

Principal Investigator:

Waldo Guerrero, MD

Northwestern Medicine Regional Medical Group

Recruiting

Winfield, Illinois, United States, 60190

Contacts

Dhruvil Pandya, MD

dhruvil.pandya2@nm.org

Principal Investigator:

Dhruvil Pandya, MD

University of Iowa

Recruiting

Iowa City, Iowa, United States, 52242

Contacts

Santiago Ortega, MD, MS

santy-ortega@uiowa.edu

Principal Investigator:

Santy Ortega-Gutierrez, MD

SSM DePaul Hospital

Recruiting

Bridgeton, Missouri, United States, 63044

Contacts

Principal Investigator:

Amer Alsheklee, MD

Saint Louis University

Recruiting

Saint Louis, Missouri, United States, 63110

Contacts

Principal Investigator:

Randall Edgell, MD

Mercy Health Neuroscience Institute

Recruiting

Toledo, Ohio, United States, 43608

Contacts

Kristine Below

KBelow@mercy.com

Principal Investigator:

Osama Zaidat, MD

Semmes Murphey Clinic

Recruiting

Memphis, Tennessee, United States, 38120

Contacts

Principal Investigator:

Lucas Elijovich, MD

More Information

Sponsor

St. Louis University

Last update posted

Feb 12, 2025

Last verified

Feb, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by St. Louis University on 2025-02-12.